You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-Cell receptor inhibitor

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Signet Ring Cell Carcinoma Trial in Hangzhou (Without any intervention)

Active, not recruiting
  • Gastric Cancer
  • Signet Ring Cell Carcinoma
  • Without any intervention
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Aug 2, 2023

NSCLC Trial in Shenyang (Sintilimab)

Unknown status
  • Non-small Cell Lung Cancer
  • Shenyang, Liaoning, China
    The First Affiliated Hospital of China Medical University
Oct 28, 2020

Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)

Recruiting
  • Type 1 Diabetes
  • ECP regular-intensity arm
  • +2 more
  • Abu Dhabi, United Arab Emirates
    Abu Dhabi Stem Cells Center
Oct 28, 2022

Diabetic Nephropathies Trial in Worldwide (BI 690517, Eplerenone, Placebo)

Completed
  • Diabetic Nephropathies
  • BI 690517
  • +2 more
  • Gentofte, Denmark
  • +39 more
Sep 16, 2020

Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular T-Cell

Recruiting
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • +13 more
  • Brentuximab Vedotin
  • Pembrolizumab
  • Chicago, Illinois
    Northwestern University
Jun 15, 2022

Scapular Dyskinesis Trial in Lahore (Stabilization Exercises, Posture Training)

Recruiting
  • Scapular Dyskinesis
  • Stabilization Exercises
  • Posture Training
  • Lahore, Punjab, Pakistan
    Jinnah Hospital, Lahore
Jun 14, 2023

Iliotibial Band Syndrome Trial in Lahore (Hip abductors stretching and strengthening exercises, Posterior oblique sling

Recruiting
  • Iliotibial Band Syndrome
  • Hip abductors stretching and strengthening exercises
  • Posterior oblique sling strengthening exercises
  • Lahore, Punjab, Pakistan
    SHAPES gymnasium
Jun 22, 2023

Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy Trial (chemo combined with PD-1 inhibitors)

Not yet recruiting
  • Esophageal Squamous Cell Carcinomas
  • +3 more
  • chemotherapy combined with PD-1 inhibitors
  • (no location specified)
Nov 17, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 23, 2022

NSCLC Trial in Worldwide (afatinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Randwick, New South Wales, Australia
  • +117 more
Aug 23, 2022

Age-related Macular Degeneration Trial in Israel, United States (OpRegen)

Completed
  • Age-Related Macular Degeneration
  • OpRegen
  • (no location specified)
Nov 1, 2022

Local Advanced Esophageal Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai cancer center
    Jun 16, 2022

    Oral Mucositis, Lymphoma, Multiple Myeloma Trial in Seoul (MIT-001, normal saline)

    Recruiting
    • Oral Mucositis
    • +3 more
    • Seoul, Korea, Republic of
    • +1 more
    Aug 9, 2022

    Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR

    Not yet recruiting
    • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
    • +6 more
      • (no location specified)
      Aug 9, 2022

      A Study of miRNA 371 in Patients With Germ Cell Tumors

      Recruiting
      • Germ Cell Tumor
      • +6 more
      • Biomarker Analysis
      • Blood Product Collection
      • Gilbert, Arizona
      • +376 more
      Mar 8, 2022

      Advanced Pancreatic Cancer Trial in Shanghai (Pimicotinib (ABSK021))

      Recruiting
      • Advanced Pancreatic Cancer
      • Pimicotinib (ABSK021)
      • Shanghai, Shanghai, China
        Renji Hospital Affiliated to Shanghai Jiaotong University School
      Oct 26, 2023

      Peripheral T/NK Cell Lymphoma (R/R PTCL) Trial (YY-20394)

      Recruiting
      • Peripheral T/NK Cell Lymphoma (R/R PTCL)
      • Houston, Texas
        MD Anderson Cancer Center
      Oct 19, 2022

      Basel Long COVID-19 Cohort Study

      Recruiting
      • Post COVID-19 Condition (PCC)
      • Data collection
      • Basel, Switzerland
        University Hospital Basel, Department of Psychosomatic Medicine
      Mar 22, 2023

      Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node

      Recruiting
      • Squamous Cell Carcinoma
      • +2 more
      • sentinel lymph node biopsy (SLNB)
      • Indianapolis, Indiana
        Indiana University Melvin & Bren Simon Cancer Center
      Nov 15, 2022

      Follicular Lymphoma Trial in Chicago (Bortezomib and Tositumomab I-131)

      Terminated
      Has Results
      • Follicular Lymphoma
      • Bortezomib and Tositumomab I-131
      • Chicago, Illinois
        Rush University Medical Center
      Oct 6, 2021

      Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

      Active, not recruiting
      • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • Tagraxofusp-erzs
      • Houston, Texas
        M D Anderson Cancer Center
      Apr 8, 2022

      Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

      Not yet recruiting
      • Advanced Melanoma
      • IMC-F106C
      • +2 more
      • La Jolla, California
      • +61 more
      Oct 31, 2023

      Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection)

      Recruiting
      • Glioblastoma
      • Glioma, Malignant
      • Biological sample collection
      • Rome, Italy
        Fondazione Policlinico Universitario A. Gemelli IRCCS
      Mar 6, 2023

      Dentin Sensitivity, Molar Incisor Hypomineralization Trial in Brescia (CPP-ACPF, PBMT, CPP-ACPF+PBMT)

      Recruiting
      • Dentin Sensitivity
      • Molar Incisor Hypomineralization
      • CPP-ACPF
      • +2 more
      • Brescia, Italy
        Dental Clinic
      Jan 21, 2023

      Advanced Solid Tumors Trial in United Kingdom, United States (axitinib, crizotinib)

      Completed
      Has Results
      • Advanced Solid Tumors
      • Chicago, Illinois
      • +16 more
      Sep 1, 2020